Pharmaceutical Executive-09-01-2007
Advertisement
Advertisement
Trending on PharmExec
1
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
2
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
3
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
4
FDA Approves Fabhalta to Slow Kidney Function Decline in Primary IgAN in Adults
5